BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrelli F, Zaniboni A, Ghidini A, Ghidini M, Turati L, Pizzo C, Ratti M, Libertini M, Tomasello G. Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis. Cancers (Basel). 2019;11. [PMID: 30999653 DOI: 10.3390/cancers11040550] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Falk W, Magnuson A, Eintrei C, Henningsson R, Myrelid P, Matthiessen P, Gupta A. Comparison between epidural and intravenous analgesia effects on disease-free survival after colorectal cancer surgery: a randomised multicentre controlled trial. Br J Anaesth 2021;127:65-74. [PMID: 33966891 DOI: 10.1016/j.bja.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Turpin A, El Amrani M, Bachet JB, Pietrasz D, Schwarz L, Hammel P. Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021. Cancers (Basel) 2020;12:E3866. [PMID: 33371464 DOI: 10.3390/cancers12123866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Lv Y, Xu M, Sun Y, Liu Y, Zhao L, Liu X, Li Z, Shi G, Jia J, Bi L, Ma N, Zhang X, Qi C. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2021;100:e26850. [PMID: 34414935 DOI: 10.1097/MD.0000000000026850] [Reference Citation Analysis]
4 Muggilli M, Russell D, Zhou Z. Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples. Cytojournal 2021;18:28. [PMID: 34876919 DOI: 10.25259/Cytojournal_78_2020] [Reference Citation Analysis]
5 Zhou L, Yu X, Li M, Gong G, Liu W, Li T, Zuo H, Li W, Gao F, Liu H. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth. EBioMedicine 2020;51:102570. [PMID: 31806563 DOI: 10.1016/j.ebiom.2019.11.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
6 Yoshino T, Argilés G, Oki E, Martinelli E, Taniguchi H, Arnold D, Mishima S, Li Y, Smruti BK, Ahn JB, Faud I, Chee CE, Yeh KH, Lin PC, Chua C, Hasbullah HH, Lee MA, Sharma A, Sun Y, Curigliano G, Bando H, Lordick F, Yamanaka T, Tabernero J, Baba E, Cervantes A, Ohtsu A, Peters S, Ishioka C, Pentheroudakis G. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol 2021:S0923-7534(21)03982-X. [PMID: 34411693 DOI: 10.1016/j.annonc.2021.08.1752] [Reference Citation Analysis]
7 Sugumar K, Hue JJ, De La Serna S, Rothermel LD, Ocuin LM, Hardacre JM, Ammori JB, Winter JM. The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysis. Cancer Rep (Hoboken) 2021;:e1390. [PMID: 34245139 DOI: 10.1002/cnr2.1390] [Reference Citation Analysis]
8 Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Li Z, Ji J. 5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last? Cancer Manag Res 2021;13:147-61. [PMID: 33469359 DOI: 10.2147/CMAR.S285361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ting FI, Sacdalan DB, Abarquez HS, Uson AJ. Treatment of cancer patients during the COVID-19 pandemic in the Philippines. Ecancermedicalscience 2020;14:1040. [PMID: 32565893 DOI: 10.3332/ecancer.2020.1040] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Kang WZ, Zhong YX, Ma FH, Liu H, Ma S, Li Y, Hu HT, Li WK, Tian YT. Treatment strategies for gastric cancer during the COVID-19 pandemic. World J Clin Cases 2020; 8(21): 5099-5103 [PMID: 33269246 DOI: 10.12998/wjcc.v8.i21.5099] [Reference Citation Analysis]
11 Watson J, Ninh MK, Ashford S, Cornett EM, Kaye AD, Urits I, Viswanath O. Anesthesia Medications and Interaction with Chemotherapeutic Agents. Oncol Ther 2021;9:121-38. [PMID: 33861416 DOI: 10.1007/s40487-021-00149-1] [Reference Citation Analysis]
12 Wei X, Gao M, Ahmed Y, Gao M, Liu W, Zhang Y, Xie X, Zhao Q, Wang H, Gu K. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein. Oncol Lett 2019;18:1607-16. [PMID: 31423228 DOI: 10.3892/ol.2019.10496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
13 St-Amour P, St-Amour P, Joliat GR, Eckert A, Labgaa I, Roulin D, Demartines N, Melloul E. Impact of ERAS compliance on the delay between surgery and adjuvant chemotherapy in hepatobiliary and pancreatic malignancies. Langenbecks Arch Surg. 2020;405:959-966. [PMID: 32918147 DOI: 10.1007/s00423-020-01981-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Alshamrani M, AlHarbi A, Alkhudair N, AlNajjar F, Khan M, Obaid AB, Khardaly A, Bajnaid E, Samarkandi H, AlAzmi A, Alabdali S, AlNahedh M. Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations. J Oncol Pharm Pract 2020;26:1429-40. [PMID: 32580641 DOI: 10.1177/1078155220935564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Domínguez Tristancho JL. Organ preservation in rectal cancer, the desire of a new paradigm. Cir Esp (Engl Ed) 2021:S0009-739X(21)00261-X. [PMID: 34544563 DOI: 10.1016/j.ciresp.2021.07.011] [Reference Citation Analysis]
17 Ahn GT, Baek SK, Han JJ, Kim HJ, Jeong SJ, Maeng CH. Optimal time interval from surgery to adjuvant chemotherapy in gastric cancer. Oncol Lett 2020;20:32. [PMID: 32774505 DOI: 10.3892/ol.2020.11893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Elekonawo FMK, Bos DL, Goldenberg DM, Boerman OC, Rijpkema M. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models. EJNMMI Res 2019;9:108. [PMID: 31828541 DOI: 10.1186/s13550-019-0580-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Pandy JG, Maaño O, Balolong-Garcia JC, Datukan JTY. Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study. Cancer Rep (Hoboken) 2021;:e1426. [PMID: 34021716 DOI: 10.1002/cnr2.1426] [Cited by in F6Publishing: 2] [Reference Citation Analysis]